Wele Clinic
Wele Clinic is a Manhattan-based private psychiatric practice founded in 2022 by Dr. Mehdi Omidvari, specializing in IV ketamine therapy, Spravato (esketamine), psychotherapy, and medication management for treatment-resistant depression and complex mental health conditions across the NYC metropolitan area.
- Company typePrivate
- Founded2022
- HeadquartersWest New York, United States
- Headcount1–10
- GTM typeB2C
- OfferingServices
What Wele Clinic does
Wele Clinic is a privately held, single-location psychiatric practice operating from 1123 Broadway in Manhattan, New York City, founded in 2022 by board-certified adult psychiatrist Dr. Mehdi Omidvari. The clinic specializes in interventional psychiatry for treatment-resistant depression and related mood and anxiety disorders, offering four core services: IV ketamine infusions, FDA-approved Spravato (esketamine) nasal spray, evidence-based psychotherapy, and pharmacological medication management. Patients are treated on-site under medical supervision with supports such as zero gravity chairs and advanced monitoring technology, and the clinic's clinical positioning targets adults who have failed to respond to at least two traditional antidepressant trials.
The underlying technology is pharmacological rather than software-based: ketamine and esketamine act on the brain's glutamate system and NMDA receptors to produce rapid-onset antidepressant effects measured in hours to days, compared with weeks for conventional SSRIs. The clinic cites outcome figures of up to 70% of treatment-resistant patients improving with ketamine therapy and approximately 64% improving within three months of Spravato treatment. Dr. Omidvari's clinical training spans Johns Hopkins (Interventional Psychiatry and TMS), SUNY Brooklyn, Mount Sinai (Psychosomatic Medicine fellowship), and NYU (psychodynamic psychotherapy), giving the practice a credentialed interventional focus.
Revenue is generated on a fee-for-service basis across all four modalities, with the clinic accepting major insurance plans including Aetna, Emblem Health, Blue Cross Blue Shield, and UnitedHealthcare, alongside out-of-pocket payment. No pricing is publicly disclosed. The clinic is a direct-to-consumer, sales-led practice with no external investors, no parent organization, and no headcount disclosures; all named evidence (six testimonials, one founder profile) indicates a founder-operated private practice. The clinic markets itself through content marketing (educational blog articles on Spravato and ketamine) and organic SEO, and claims a service catchment spanning all five NYC boroughs plus Jersey City and Long Island.
Wele Clinic firmographics
Firmographics- Name
- Wele Clinic
- Legal name
- Wele Clinic
- Website
- https://weleclinicnyc.com
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Wele Clinic is a Manhattan-based private psychiatric practice founded in 2022 by Dr. Mehdi Omidvari, specializing in IV ketamine therapy, Spravato (esketamine), psychotherapy, and medication management for treatment-resistant depression and complex mental health conditions across the NYC metropolitan area.
- Ownership category
- akta.pro rank
Wele Clinic industry classification
Industry- Product category
- Psychiatric Services
- NAICS
- Offices of Physicians, Mental Health Specialists (621112), Outpatient Mental Health and Substance Abuse Centers (621420)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)
- akta.pro primary industry
- Outpatient Mental Health Clinics & Counseling Centers (HLAFACAA)
- akta.pro secondary industry
- Outpatient Mental Health & Counseling Clinics (HLAFABAC)
Keywords
Where Wele Clinic is headquartered
LocationHeadquarters
- HQ city
- West New York
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Wele Clinic business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D
Revenue model
- Psychiatric Treatment Services: Fee-for-service medical services including ketamine therapy sessions, Spravato treatments, psychotherapy sessions, and medication management. Patients pay via insurance or out-of-pocket, with the clinic accepting major insurance providers including Aetna, Emblem Health, Blue Cross Blue Shield, and UnitedHealthcare.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Wele Clinic product offering
Product offeringCore offering
Wele Clinic provides outpatient psychiatric care specializing in interventional treatments for treatment-resistant depression, including IV ketamine infusions, FDA-approved Spravato (esketamine) nasal spray, psychotherapy, and medication management. Patients begin with a comprehensive psychiatric evaluation and receive personalized treatment plans combining medication and therapy approaches.
Product overview
Wele Clinic is a mental health and psychiatric clinic offering a coordinated suite of treatments led by Dr. Mehdi Omidvari: Ketamine Therapy (IV infusions for treatment-resistant depression, PTSD, anxiety, OCD), Spravato Treatment (FDA-approved esketamine nasal spray for treatment-resistant depression), Psychotherapy (evidence-based talk therapy sessions), and Medication Management (pharmacological treatment planning and monitoring). The clinic specializes in innovative, rapid-acting treatments for patients who have not responded to traditional antidepressants, serving Manhattan and the greater New York City area.
Differentiator
Problem solved
Functional benefit
Products and services
- Ketamine Therapy Innovative IV ketamine treatments for rapid mental health relief, targeting the brain's glutamate system to reset neural circuits affected by treatment-resistant depression, PTSD, anxiety, and OCD. Administered to individual patients at the Manhattan clinic by a board-certified psychiatrist.
- Spravato Treatment FDA-approved esketamine nasal spray administered under clinical supervision for treatment-resistant depression and major depressive disorder with suicidal ideation. Targets NMDA receptors in the glutamate system for rapid-acting antidepressant effects, often covered by major insurance plans.
- Psychotherapy Evidence-based psychotherapy sessions addressing mood and anxiety disorders, ADHD, trauma-related issues, sleep issues, stress management, self-esteem, relationship concerns, and compulsions. Provided to individual patients in the NYC metropolitan area.
- Medication Management Expert pharmacological medication management plans for depression and anxiety, including evaluation, prescription, initiation, monitoring, and ongoing review of psychiatric medications to ensure effectiveness and safety for individual patients.
Quantifiable outcome
- Up to 70% of patients with treatment-resistant depression experience significant improvement with ketamine therapy
- +2 more outcomes
Companies that use Wele Clinic
Customer profileNamed customers6 records
Segments3 records
Ideal customer profiles2 records
Wele Clinic technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Wele Clinic partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Emblem HealthminorEmblem Health is accepted as an insurance provider at Wele Clinic, allowing insured patients to access psychiatric services including ketamine therapy, Spravato treatment, psychotherapy, and medication management.
Scale indicators1 record
Recent moves5 records
Expansion highlights4 records
Wele Clinic competitors and assessment
Company assessmentOthers
- ARC Health: Outpatient behavioral health platform partnering with psychiatric practices. Potentially comparable as a strategic partner or roll-up acquirer of independent psychiatric clinics like Wele Clinic.
- Lyra Health: Employer-sponsored mental health benefit platform that connects employees to in-network therapists and psychiatrists. Comparable as a referral ecosystem participant that channels patients to clinics like Wele Clinic.
- Spring Health: Employer mental health benefits provider with a network of therapy and psychiatry providers. Comparable as a referral channel that could direct patients to in-network interventional psychiatry clinics like Wele Clinic.
Regional players
- Done. Telehealth ADHD and psychiatric care provider. Comparable in psychiatric services delivery but focused on stimulant medication management for ADHD rather than treatment-resistant depression or interventional psychiatry.
Direct peers
- Field Trip Health: Ketamine-assisted psychotherapy clinic chain (now operating as Stella) offering psychedelic-assisted mental health treatments. Comparable to Wele Clinic in ketamine-based treatment model and treatment-resistant patient focus.
- Bespoke Treatment: Multi-state interventional psychiatry provider offering IV ketamine, Spravato, and TMS for treatment-resistant depression and anxiety. Directly comparable to Wele Clinic in modality mix, patient segment, and physician-led clinical model.
Emerging players
- Nue Life: Ketamine therapy platform combining in-clinic infusions with digital mental health support. Comparable in ketamine treatment offering and treatment-resistant patient focus, though with a hybrid digital model.
- Mindbloom: At-home ketamine therapy provider serving patients across multiple U.S. states. Comparable as a competitor for ketamine treatment-seeking patients, though operating through a remote/guided model rather than in-clinic.
Broad incumbents
- Talkiatry: Tech-enabled psychiatric practice group operating across multiple states with in-network insurance coverage. Comparable to Wele Clinic in psychiatric services and insurance-accepting model, though broader in scope and lacking interventional psychiatry specialization.
- Cerebral: Large-scale telehealth mental health provider offering medication management and therapy. Comparable to Wele Clinic in medication management and psychiatric services, though Cerebral operates primarily via telehealth rather than in-person interventional care.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Wele Clinic social profiles
Digital presenceWele Clinic financial estimates
Financial estimateRevenue estimate
Valuation estimate
Wele Clinic leadership team
Management profileNumber of profiles
Profiles1 record
Wele Clinic funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Wele Clinic M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Wele Clinic
What does Wele Clinic do?
Wele Clinic provides outpatient psychiatric care specializing in interventional treatments for treatment-resistant depression, including IV ketamine infusions, FDA-approved Spravato (esketamine) nasal spray, psychotherapy, and medication management. Patients begin with a comprehensive psychiatric evaluation and receive personalized treatment plans combining medication and therapy approaches.
Is Wele Clinic a public or private company?
Wele Clinic is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Wele Clinic founded?
Wele Clinic was founded in 2022. It employs 1 to 10 people.
Where is Wele Clinic based?
Wele Clinic is headquartered in West New York, United States, in the North America region.
How does Wele Clinic make money?
One revenue line is on record: psychiatric Treatment Services.
Who are Wele Clinic's main competitors?
Others on record are ARC Health, Lyra Health and Spring Health. Done. is listed as a regional player. Direct peers are Field Trip Health and Bespoke Treatment. Emerging players are Nue Life and Mindbloom. Broad incumbents are Talkiatry and Cerebral.
Does Wele Clinic have an API?
No public API is recorded for Wele Clinic.
What industry is Wele Clinic in?
Wele Clinic's product category is Psychiatric Services. Its primary akta.pro industry code is HLAFACAA, Outpatient Mental Health Clinics & Counseling Centers, with a secondary code of HLAFABAC, Outpatient Mental Health & Counseling Clinics. Its NAICS code is 621112 and its SIC code is 8011.